4//SEC Filing
Schlanger David J 4
Accession 0001551306-24-000051
CIK 0001551306other
Filed
Mar 28, 8:00 PM ET
Accepted
Mar 29, 7:01 PM ET
Size
8.9 KB
Accession
0001551306-24-000051
Insider Transaction Report
Form 4
Progyny, Inc.PGNY
Schlanger David J
DirectorExecutive Chairman
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2024-03-27−71,272→ 1,310,022 totalExercise: $3.95Exp: 2029-05-23→ Common Stock (71,272 underlying) - Exercise/Conversion
Common Stock
2024-03-27$3.95/sh+71,272$281,845→ 157,584 total - Sale
Common Stock
2024-03-27$37.80/sh−71,272$2,694,267→ 86,312 total
Footnotes (3)
- [F1]Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 23, 2023.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.50 to $38.17, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote
- [F3]These options are fully vested and exercisable.
Documents
Issuer
Progyny, Inc.
CIK 0001551306
Entity typeother
Related Parties
1- filerCIK 0001576145
Filing Metadata
- Form type
- 4
- Filed
- Mar 28, 8:00 PM ET
- Accepted
- Mar 29, 7:01 PM ET
- Size
- 8.9 KB